{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T06:12:36Z","timestamp":1788502356025,"version":"build-2803163510"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Chronic pancreatitis (CP) creates an inflammatory pancreatic microenvironment and is an established risk factor for pancreatic cancer (PC). However, immune-inflammatory links between CP and PC remain unclear. Isorhamnetin (ISO), a natural flavonoid with anti-inflammatory and antitumor activities, may influence pancreatic inflammatory signaling. This study investigated ISO-associated molecular networks shared by CP and PC, examined the relationships between prioritized targets and transcriptome-estimated immune-cell infiltration, and evaluated the effects of ISO in pancreatic cancer cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>CP- and PC-associated targets were collected from disease databases, and ISO targets were obtained from drug-target prediction platforms. Disease- and ISO-related targets were analyzed using protein\u2013protein interaction networks, functional enrichment, and hub-gene screening. The expression, prognostic relevance, diagnostic performance, and immune infiltration associations of hub genes were evaluated using TCGA-PAAD, GTEx, Kaplan\u2013Meier Plotter, ROC analysis, and CIBERSORTx. Molecular docking and 100 ns molecular dynamics simulations assessed ISO\u2013target binding stability. Two-sample Mendelian randomization (MR) explored potential causal associations between genetically proxied circulating levels of the six hub proteins and CP or PC risk. The effects of ISO on proliferation, wound closure, apoptosis, and target protein expression were examined in PANC-1 and BXPC-3 cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      372 overlapping CP- and PC-associated targets and 48 ISO-related targets were identified. EGFR, AKT1, MMP9, BCL2, TNF, and IL6 were screened as hub genes. Functional enrichment indicated targets were involved in inflammatory responses, cytokine-related signaling, apoptosis regulation, epithelial proliferation, pancreatic cancer-related pathways, and PI3K-Akt signaling. Hub-gene expression was correlated with CIBERSORTx-estimated immune-cell fractions, including activated natural killer cells and several T-cell subsets. Molecular docking and molecular dynamics simulations provided preliminary support for ISO\u2013target interactions and complex stability. Across the 12 prespecified protein\u2013outcome combinations, MMP9\u2013CP was the only nominal IVW association.\n                      <jats:italic>In vitro<\/jats:italic>\n                      , ISO reduced the viability and wound closure of PANC-1 and BXPC-3 cells, promoted apoptosis, and decreased EGFR, AKT1, BCL2, and TNF-\u03b1 protein expression in a concentration-dependent manner.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>ISO may influence CP- and PC-associated molecular networks through multitarget regulation involving EGFR, AKT1, MMP9, BCL2, TNF, and IL6. These findings provide hypothesis-generating computational, genetic, and cellular evidence supporting investigation of ISO in pancreatic inflammation-associated tumor biology. However, immune regulatory effects, MMP9\/IL6 protein modulation, and EGFR\/AKT pathway activation require further experimental validation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1902080","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T05:29:25Z","timestamp":1788499765000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated analysis of isorhamnetin-associated targets in chronic pancreatitis and pancreatic cancer: immune-infiltration associations and antitumor effects in pancreatic cancer cells"],"prefix":"10.3389","volume":"17","author":[{"given":"Ming","family":"Xu","sequence":"first","affiliation":[{"name":"The School of Basic Medical Sciences, Qilu Medical University","place":["Zibo, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renren","family":"Sun","sequence":"additional","affiliation":[{"name":"The School of Basic Medical Sciences, Qilu Medical University","place":["Zibo, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[{"name":"The School of Basic Medical Sciences, Qilu Medical University","place":["Zibo, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wei","sequence":"additional","affiliation":[{"name":"The School of Basic Medical Sciences, Qilu Medical University","place":["Zibo, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Li","sequence":"additional","affiliation":[{"name":"The School of Basic Medical Sciences, Qilu Medical University","place":["Zibo, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Li","sequence":"additional","affiliation":[{"name":"The School of Basic Medical Sciences, Qilu Medical University","place":["Zibo, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Hou","sequence":"additional","affiliation":[{"name":"The School of Basic Medical Sciences, Qilu Medical University","place":["Zibo, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiping","family":"Xie","sequence":"additional","affiliation":[{"name":"The School of Basic Medical Sciences, North China University of Science and Technology","place":["Tangshan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelin","family":"Xu","sequence":"additional","affiliation":[{"name":"The School of Basic Medical Sciences, Qilu Medical University","place":["Zibo, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/mog.0b013e3282ba5736","article-title":"Chronic pancreatitis","volume":"396","author":"Georg","year":"2020","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v29.i30.4671","article-title":"Incidence, prevalence, and comorbidities of chronic pancreatitis: A 7-year population-based study","volume":"29","author":"Qiu-Yu","year":"2023","journal-title":"World J Gastroenterol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/js9.0000000000000326","article-title":"Effectiveness and safety of central pancreatectomy in benign or low-grade Malignant pancreatic body lesions: a systematic review and meta-analysis","volume":"109","author":"Shiyuan","year":"2023","journal-title":"Int J Surg"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/sla.0000000000006157","article-title":"Tailoring the use of central pancreatectomy through prediction models for major morbidity and postoperative diabetes: International retrospective multicenter study","volume":"280","author":"Eduard Antonie","year":"2023","journal-title":"Ann Surg"},{"key":"B5","doi-asserted-by":"publisher","first-page":"217662","DOI":"10.1016\/j.canlet.2025.217662","article-title":"Pancreatic cancer precursor lesions - Can immunotherapy prevent progression into pancreatic ductal adenocarcinoma","volume":"619","author":"Thomas","year":"2025","journal-title":"Cancer Lett"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.02.014","article-title":"Pancreatic cancer: Advances and challenges","volume":"186","author":"Christopher","year":"2023","journal-title":"Cell"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-023-00840-w","article-title":"Therapeutic developments in pancreatic cancer","volume":"21","author":"Z Ian","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"bbad344","DOI":"10.1101\/2023.04.23.538005","article-title":"Comparative study of the mechanism of natural compounds with similar structures using docking and transcriptome data for improving in silico herbal medicine experimentations","volume":"24","author":"Musun","year":"2023","journal-title":"Brief Bioinform"},{"key":"B9","doi-asserted-by":"publisher","first-page":"118841","DOI":"10.1016\/j.jep.2024.118841","article-title":"Systematic pharmacology and experimental validation to elucidate the inflammation-associated mechanism of Huanglian Wendan (HLWD) decoction in the treatment of MAFLD associated with atherosclerosis","volume":"337","author":"Zhi-Chao","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.3389\/fphar.2020.01194","article-title":"Editorial: Network pharmacology and traditional medicine","volume":"11","author":"Xinxing","year":"2020","journal-title":"Front Pharmacol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.0c01452","article-title":"Lean-Docking: Exploiting ligands' predicted docking scores to accelerate molecular docking","volume":"61","author":"Francois","year":"2021","journal-title":"J Chem Inf Model"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/cbdd.14038","article-title":"Application of molecular dynamics simulation in biomedicine","volume":"99","author":"Xiaodong","year":"2022","journal-title":"Chem Biol Drug Des"},{"key":"B13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1101\/cshperspect.a038984","article-title":"Mendelian randomization","volume":"2","author":"Eleanor","year":"2022","journal-title":"Nat Rev Methods Primers"},{"key":"B14","doi-asserted-by":"publisher","first-page":"110301","DOI":"10.1016\/j.biopha.2020.110301","article-title":"Isorhamnetin: A review of pharmacological effects","volume":"128","author":"Gang","year":"2020","journal-title":"BioMed Pharmacother"},{"key":"B15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s12672-025-03265-w","article-title":"Progress in the antitumor molecular mechanisms of Isorhamnetin","volume":"17","author":"Anyang","year":"2025","journal-title":"Discov Oncol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"7381","DOI":"10.3390\/ijms26157381","article-title":"Isorhamnetin: Reviewing recent developments in anticancer mechanisms and nanoformulation-driven delivery","volume":"26","author":"Juie Nahushkumar","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.09.105","article-title":"Isorhamnetin suppresses PANC-1 pancreatic cancer cell proliferation through S phase arrest","volume":"108","author":"Jia-Li","year":"2018","journal-title":"BioMed Pharmacother"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Paul","year":"2003","journal-title":"Genome Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1097403","DOI":"10.3389\/fimmu.2023.1097403","article-title":"NCAPG2 could be an immunological and prognostic biomarker: From pan-cancer analysis to pancreatic cancer validation","volume":"14","author":"Qi","year":"2023","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1117585","DOI":"10.3389\/fimmu.2023.1117585","article-title":"Comprehensively prognostic and immunological analysis of snail family transcriptional repressor 2 in pan-cancer and identification in pancreatic carcinoma","volume":"14","author":"Dandan","year":"2023","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: An open chemical toolbox","volume":"3","author":"Noel","year":"2011","journal-title":"J Cheminform"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s10822-010-9352-6","article-title":"Ligand docking and binding site analysis with PyMOL and Autodock\/Vina","volume":"24","author":"Daniel","year":"2010","journal-title":"J Comput-Aided Mol Des"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.3390\/ph17121715","article-title":"In silico evaluation of potential NDM-1 inhibitors: An integrated docking and molecular dynamics approach","volume":"17","author":"Eduvan","year":"2025","journal-title":"Pharm (Basel)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Oleg","year":"2009","journal-title":"J Comput Chem"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2147\/dddt.s522381","article-title":"Exploratory study on the role of emodin in alleviating MPTP-induced neurotoxicity: A focus on p53-ferroptosis signaling","volume":"19","author":"Yujun","year":"2025","journal-title":"Drug Des Devel Ther"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0175-2","article-title":"Genomic atlas of the human plasma proteome","volume":"558","year":"2018","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population","volume":"613","author":"I","year":"2023","journal-title":"Nature"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-021-00931-x","article-title":"A cross-population atlas of genetic associations for 220 human phenotypes","volume":"53","author":"Sakaue","year":"2021","journal-title":"Nat Genet"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1021\/acsbiomaterials.2c00933","article-title":"Nanoceria ameliorates fibrosis, inflammation, and cellular stress in experimental chronic pancreatitis","volume":"9","author":"Amit","year":"2023","journal-title":"ACS Biomater Sci Eng"},{"key":"B30","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3390\/pharmaceutics16050611","article-title":"The role of a cholecystokinin receptor antagonist in the management of chronic pancreatitis: A phase 1 trial","volume":"16","author":"Victor","year":"2024","journal-title":"Pharmaceutics"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-330155","article-title":"DNA-methylation signature accurately differentiates pancreatic cancer from chronic pancreatitis in tissue and plasma","volume":"72","author":"Yenan","year":"2023","journal-title":"Gut"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-025-02321-0","article-title":"Mortality and cancer risk in patients with chronic pancreatitis in Japan: Insights into the importance of surveillance for pancreatic cancer","volume":"61","author":"Ryotaro","year":"2025","journal-title":"J Gastroenterol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s12032-025-02811-4","article-title":"Cancer network pharmacology: Multi-network regulatory mechanisms and future directions","volume":"42","author":"Zixuan","year":"2025","journal-title":"Med Oncol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-022-02587-1","article-title":"Muc4 loss mitigates epidermal growth factor receptor activity essential for PDAC tumorigenesis","volume":"42","author":"Rakesh","year":"2023","journal-title":"Oncogene"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.12.002","article-title":"EGFR-activated myofibroblasts promote metastasis of pancreatic cancer","volume":"42","author":"Gianluca","year":"2024","journal-title":"Cancer Cell"},{"key":"B36","doi-asserted-by":"publisher","first-page":"116509","DOI":"10.1016\/j.bcp.2024.116509","article-title":"The LAMB3-EGFR signaling pathway mediates synergistic anti-cancer effects of berberine and emodin in pancreatic cancer","volume":"228","author":"Caiming","year":"2024","journal-title":"Biochem Pharmacol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-024-01259-9","article-title":"Decoding p53 tumor suppression: A crosstalk between genomic stability and epigenetic control","volume":"32","author":"Ana","year":"2024","journal-title":"Cell Death Differ"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06102-8","article-title":"Deterministic evolution and stringent selection during preneoplasia","volume":"618","author":"Kasper","year":"2023","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s42003-025-09465-y","article-title":"The p53 R181C mutation accumulates through impaired deacetylation by Sirt1 and facilitates tumor development","volume":"9","author":"Erli","year":"2026","journal-title":"Commun Biol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"119648","DOI":"10.1016\/j.jep.2025.119648","article-title":"Mechanism of ethyl acetate fraction of Amorphophallus konjac against breast cancer based on network pharmacology, molecular docking and experimental validation","volume":"345","author":"Huimin","year":"2025","journal-title":"J Ethnopharmacol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"119135","DOI":"10.1016\/j.jep.2024.119135","article-title":"Xiaoai Jiedu recipe reduces cell survival and induces apoptosis in hepatocellular carcinoma by stimulating autophagy via the AKT\/mTOR pathway","volume":"339","author":"Yi","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-023-00629-4","article-title":"Mechanisms of BCL-2 family proteins in mitochondrial apoptosis","volume":"24","author":"Peter","year":"2023","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-025-02036-x","article-title":"Assessment of the effect of Lasianthera africana on interleukin-6, tumor necrosis factor-alpha and other inflammatory markers in inflamed wistar rats","volume":"33","author":"Eleazar Chukwuemeka","year":"2025","journal-title":"Inflammopharmacology"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1093990","DOI":"10.3389\/fimmu.2022.1093990","article-title":"The immunomodulatory role of matrix metalloproteinases in colitis-associated cancer","volume":"13","author":"Luying","year":"2023","journal-title":"Front Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e162054","DOI":"10.1172\/jci162054","article-title":"Morphology-guided transcriptomic analysis of human pancreatic cancer organoids reveals microenvironmental signals that enhance invasion","volume":"133","author":"Yea Ji","year":"2023","journal-title":"J Clin Invest"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.cir-21-0946","article-title":"Systemic alterations in type-2 conventional dendritic cells lead to impaired tumor immunity in pancreatic cancer","volume":"11","author":"C Alston","year":"2023","journal-title":"Cancer Immunol Res"},{"key":"B47","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1186\/s12967-023-04302-4","article-title":"High glucose-upregulated PD-L1 expression through RAS signaling-driven downregulation of PTRH1 leads to suppression of T cell cytotoxic function in tumor environment","volume":"21","author":"Chenggang","year":"2023","journal-title":"J Transl Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e15585","DOI":"10.1002\/advs.202515585","article-title":"IL-4\/STAT6-signaling influences local inflammation and regeneration processes during acute pancreatitis and promotes fibrosis by a direct activation of pancreatic fibroblasts during chronic pancreatitis","volume":"13","author":"Hager","year":"2026","journal-title":"Adv Sci (Weinh)"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1902080\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T05:29:26Z","timestamp":1788499766000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1902080\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":48,"alternative-id":["10.3389\/fimmu.2026.1902080"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1902080","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"article-number":"1902080"}}